Galen Growth

Decision-Grade Digital Health Intelligence

Basel, Basel-Stadt, Switzerland

Growth

Galen Growth helps healthcare organisations make more informed decisions about Digital Health innovation, powered by their proprietary intelligence platform, HealthTech Alpha.

★★★★★4.8 · 1 review

Shareable draft

Check out Galen Growth on @MedStartr Today Galen Growth helps healthcare organisations make more informed decisions about Digital Health innovation, powered by their proprietary intelligence platform, HealthTech Alpha. https://www.linkedin.com/company/galen-growth/ #MedMo #MedStartrVentures

https://www.medstartr.ai/s/G1LDYTMSI5Q

Get Involved in Galen Growth

10 engagements

How We Help

Photos & Videos

Previous logo

Leadership

Julien de Salaberry, MBA

Primary Contact

Problem Statement

Healthcare organizations struggle to make informed decisions about digital health innovation. They need to know where the market is moving, which technologies matter, and where competitors are placing bets.

Core Technology

Data & Analytics Platform

Key Differentiators

Proprietary Digital Health intelligence platform (HealthTech Alpha) combining global data with a specialist taxonomy and deep expertise.

Clinical Focus

Digital Health Strategy

Target Customers

Healthcare companies, investors, health systems, and professional-services firms.

Product Stage

Mature

Company Info

Business Model: B2B SaaS
Founded: 2016
Website: www.galengrowth.com/healthtech-alpha-digital-health-intelligence/?utm_source=medstartr&utm_medium=referral&utm_campaign=hta_general

🌐Website 💼LinkedIn

MedStartr Engagement Score

205

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Reviews

★★★★★4.8 · 1 review

Julien de SalaberryJul 13, 2026
★★★★★4.8
- Clinical Benefit Potential 5/5
- Feasibility 5/5
- Innovativeness 5/5
- Scalability 4/5
Clinical Benefit Potential
helps people assess innovations
Innovativeness
Very good data, best in the biz!

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Galen Growth?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.

Get Involved in Galen Growth

10 engagements